High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - Am Diabetes Assoc
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …
被引用次数：521 相关文章

High-Dose Resveratrol Supplementation in Obese Men.

MM Poulsen, PF Vestergaard, BF Clasen… - …, 2013 - search.ebscohost.com
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …
[PDF] archive.org

[PDF][PDF] An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - scholar.archive.org
RESEARCH DESIGN AND METHODS Ethical approval. All participants were given oral and
written information before written informed consent was obtained. The protocol was …

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - 2013 - cabidigitallibrary.org
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2012 - europepmc.org
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - 2013 - pubmed.ncbi.nlm.nih.gov
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …

High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - search.proquest.com
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …

High-Dose Resveratrol Supplementation in Obese Men

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - cir.nii.ac.jp
抄録< jats: p> Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for
morbidity and premature mortality. Based on animal and in vitro studies, resveratrol reverts …
[PDF] researchgate.net

[PDF][PDF] An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - 2013 - researchgate.net
RESEARCH DESIGN AND METHODS Ethical approval. All participants were given oral and
written information before written informed consent was obtained. The protocol was …
[HTML] nih.gov

[HTML][HTML] High-Dose Resveratrol Supplementation in Obese Men: An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism …

MM Poulsen, PF Vestergaard, BF Clasen, Y Radko… - Diabetes, 2013 - ncbi.nlm.nih.gov
Obesity, diabetes, hypertension, and hyperlipidemia constitute risk factors for morbidity and
premature mortality. Based on animal and in vitro studies, resveratrol reverts these risk …